These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26436385)

  • 41. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
    Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
    J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD1d blockade suppresses the capacity of immature dendritic cells to prime allogeneic T cell response.
    Ma ZH; Lu H; Lu Q; Yao ZF; Han Y
    J Surg Res; 2013 Aug; 183(2):894-9. PubMed ID: 23478084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B; Li DP; Xu KL; Pan XY
    Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Application of pseudotyped lentivirus-mediated double suicide genes to allogeneic bone marrow transplantation in mice].
    Jiang YR; Chen XL; Ma DX; Liu CS
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):82-6. PubMed ID: 14990045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of murine acute graft-versus-host disease by recipient-derived TGFbeta1-treated dendritic cells.
    Mou HB; Lin MF; Cen H; Huang H; Cai Z
    Transplant Proc; 2004 Jun; 36(5):1604-6. PubMed ID: 15251394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo administration of interleukin-6 in murine allogeneic bone marrow chimeras: early and delayed enhancement of hematopoiesis accompanied with split tolerance but not with graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Tanaka J; Imai K; Han M; Fujii Y; Kobayashi M; Higa T; Kasai M
    Immunobiology; 1994 Jun; 190(4-5):346-67. PubMed ID: 7982720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.
    Lu SX; Kappel LW; Charbonneau-Allard AM; Atallah R; Holland AM; Turbide C; Hubbard VM; Rotolo JA; Smith M; Suh D; King C; Rao UK; Yim N; Bautista JL; Jenq RR; Penack O; Na IK; Liu C; Murphy G; Alpdogan O; Blumberg RS; Macian F; Holmes KV; Beauchemin N; van den Brink MR
    PLoS One; 2011; 6(7):e21611. PubMed ID: 21760897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Influence of donor Treg cells on GVHD and GVL effects after allogeneic bone marrow transplantation in mice].
    Cao J; Chen C; Zeng LY; Li ZY; Cheng H; Pan XY; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):181-4. PubMed ID: 20137143
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytosine-Phosphorothionate-Guanine Oligodeoxynucleotides Exacerbates Hemophagocytosis by Inducing Tumor Necrosis Factor-Alpha Production in Mice after Bone Marrow Transplantation.
    Liu J; Guo YM; Onai N; Ohyagi H; Hirokawa M; Takahashi N; Tagawa H; Ubukawa K; Kobayashi I; Tezuka H; Minamiya Y; Ohteki T; Sawada K
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):627-636. PubMed ID: 26740374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Blockage of Th17 cells differentiation exacerbated mouse acute intestine graft-versus-host disease following allogeneic bone marrow transplantation].
    Li HJ; Cheng H; Pan B; Zeng LY; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1024-7. PubMed ID: 23363796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Influence of intra-bone marrow infusion of donor lymphocytes on development of graft-versus-host disease and level of IL-4 and IFN-gamma in peripheral blood].
    Bi YZ; Zeng DX; Sheng GF; Chen BA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1538-40. PubMed ID: 20030942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantation.
    Ewing P; Hildebrandt GC; Planke S; Andreesen R; Holler E; Gerbitz A
    Int J Mol Med; 2007 Sep; 20(3):301-8. PubMed ID: 17671733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
    Xu J; Wei J; Huang M; Zhu X; Guan J; Yin J; Xiao Y; Zhang Y
    Int Immunopharmacol; 2013 Nov; 17(3):601-7. PubMed ID: 23993943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid lethality of hosts by interleukin-12 following H-2 compatible allogeneic bone marrow transplantation: Reminiscence of gut-associated acute graft-versus-host reaction.
    Schmitt M; Taniguchi M; Yoshida T; Miyahara Y; Gu X; Mukai K; Yagita H; Dohner H; Shiku H
    Int J Oncol; 2002 Oct; 21(4):795-801. PubMed ID: 12239618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects.
    Reddy P; Teshima T; Hildebrandt G; Williams DL; Liu C; Cooke KR; Ferrara JL
    Blood; 2003 Apr; 101(7):2877-85. PubMed ID: 12433681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study of relieving graft-versus-host disease by blocking CD137-CD137 ligand costimulatory pathway in vitro.
    Xu K; Li C; Pan X; Du B
    Int J Hematol; 2007 Jul; 86(1):84-90. PubMed ID: 17675273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation.
    Sun K; Hsiao HH; Li M; Ames E; Bouchlaka M; Welniak LA; Hagino T; Jagdeo J; Pai CC; Chen M; Blazar BR; Abedi M; Murphy WJ
    J Immunol; 2012 Aug; 189(4):2033-42. PubMed ID: 22778394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Transforming growth factor beta alleviates acute graft-versus-host-disease after allogeneic bone marrow transplantation in murine model].
    Wang YN; Feng CC; Liu JL; Li F; Fu L; Wang Z
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1135-9. PubMed ID: 18928612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.